▼ -10.66% Downside Potential
This price target is based on 23 analysts offering 12 month price targets for Corteva in the last 3 months. The average price target is $34.37, with a high forecast of $42.00 and a low forecast of $24.00. The average price target represents a -10.66% upside from the last price of $38.47.
The current consensus among 23 polled investment analysts is to hold stock in Corteva. This rating has held steady since June 2020, when it changed from a Buy consensus rating.
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and disease, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, below-ground nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. is headquartered in Wilmington, Delaware.